Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOFIRINOX
2011-004406-25Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxaliplatin, irinotecan, folinic acid and fluorouracil in rectal cancer, sponsored by Unicancer. Started Oct 2011; status: completed.
02
Drugs
oxaliplatinirinotecanfolinic acidfluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2011-004406-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004406-25.